Nerve growth factor antibody exacerbates neuropathological signs of experimental allergic encephalomyelitis in adult lewis rats

J Neuroimmunol. 2000 May 1;104(2):116-23. doi: 10.1016/s0165-5728(99)00272-6.

Abstract

In this study, experimental allergic encephalomyelitis (EAE) rats and rats exhibiting EAE expressing high circulating anti-nerve growth factor antibody were daily monitored for clinical signs and chronic relapses. Eighty-five days after EAE induction, blood, spinal cord and brain stem were used for histological examination, nerve growth factor (NGF) and brain derived neurotrophic factor (BDNF) evaluation. The results showed that NGF-deprived rats display more severe clinical signs of disease. These effects were associated with a significant reduction of NGF in the brain stem and spinal cord but not of BDNF, which decreased only in spinal cord. These observations provide additional support to the hypothesis of a protective NGF role in rats exhibiting EAE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Animals
  • Autoantibodies / blood*
  • Brain Stem / metabolism*
  • Brain Stem / pathology
  • Brain-Derived Neurotrophic Factor / blood
  • Brain-Derived Neurotrophic Factor / metabolism*
  • Chronic Disease
  • Encephalomyelitis, Autoimmune, Experimental / immunology
  • Encephalomyelitis, Autoimmune, Experimental / metabolism*
  • Encephalomyelitis, Autoimmune, Experimental / pathology*
  • Female
  • Nerve Growth Factor / blood
  • Nerve Growth Factor / immunology
  • Nerve Growth Factor / metabolism*
  • Rats
  • Rats, Inbred Lew
  • Recurrence
  • Specific Pathogen-Free Organisms
  • Spinal Cord / metabolism*
  • Spinal Cord / pathology
  • Time Factors

Substances

  • Autoantibodies
  • Brain-Derived Neurotrophic Factor
  • Nerve Growth Factor